Regulator makes record illicit weight loss medicine seizure

Officers from the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) have made a record seizure at an illicit weight loss medicine production facility.

(c) Towfiqu Barbhuiya/Unsplash

(c) Towfiqu Barbhuiya/Unsplash

The seizure of thousands retatrutide and tirzepatide pens with a street value of over £250,000 was made at an industrial estate on the outskirts of Northampton.

Secretary of state for health and social care, Wes Streeting, said: ‘This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and illegal weight loss jabs to make a quick buck. 

‘These unregulated products, made with no regard for safety or quality, posed a major risk to unwitting customers. 

"My message is clear: don't buy weight loss medications from unregulated sources. Talk to your GP, seek NHS advice, and don't line the pockets of criminals who don't care about your health. Safe, appropriate, licensed obesity drugs can greatly benefit those in need if taken under medical supervision, and I urge people to only purchase and use them with the approval and oversight of medics and pharmacists.'

Andy Morling, head of the MHRA's CEU, said:‘Taking out the first illicit weight loss medicine manufacturing facility found in the UK is a landmark result for the MHRA and a major blow to the illegal trade. These products are untested, unauthorised, and potentially deadly. By taking this organised criminal network out of operation and stopping tens of thousands of potentially fatal products from entering circulation, we've prevented a serious risk to public health.'

THE BIG INTERVIEW: Back of the queue

THE BIG INTERVIEW: Back of the queue

By Lee Peart 26 June 2026

Mark Dayan, Nuffield Trust policy analyst, finds the benefits of leaving the EU have been few and far between for the NHS.

EXCLUSIVE: NHS heroes recognised after accelerating cancer diagnosis and transforming patient care

By Lee Peart 11 June 2026

Groundbreaking NHS teams that have freed up thousands of hospital beds, accelerated cancer diagnosis and transformed care for patients have been recognised a...

Clinicians 'unfairly exposed' to costly AI negligence claims

By Lee Peart 09 June 2026

The widening gap between regulation and rapid adoption of AI in healthcare leaves clinicians ‘unfairly exposed’ to costly negligence claims, according to the...


Popular articles by Lee Peart